Boncure Injection (Ibandronate Sodium Trihydrate)
Ibandronate Sodium Monohydrate 3.375mg
Injections · Prescription medication
Lite Pharmtech Co., Ltd.
MFDS item code 201504116 · Notified 2015.06.24 · Insurance code 690300461
Improvement of postmenopausal osteoporosis.
This medication is used to treat osteoporosis commonly occurring in postmenopausal women. It helps to increase bone density, enhance bone strength, and reduce the risk of fractures. Therefore, it is effective in preventing fractures due to osteoporosis and maintaining bone health.
Administer 3mg intravenously once every 3 months over 15 - 30 seconds.
This medication must be administered intravenously, as administration into arteries or around veins may cause tissue damage. Patients with a known allergy to this medication or its components, as well as those with untreated hypocalcemia, should not use this drug. Potential side effects during use may include gastrointestinal issues, muscle pain, joint pain, fatigue, headaches, and rashes, which are mostly mild to moderate. Some patients have reported transient influenza-like symptoms, vasculitis, hypersensitivity reactions, and severe skin reactions. Osteonecrosis of the jaw can occur rarely, so cancer patients or those with poor oral hygiene should receive dental care beforehand and avoid excessive dental treatment while under therapy. Patients receiving this medication should ensure adequate intake of calcium and vitamin D, and regular check-ups are necessary if they have renal function issues or other diseases. If pain in the thigh or groin occurs, the possibility of atypical fractures should be suspected, and consultation with a physician is recommended. It is safer for pregnant or breastfeeding women not to use this medication, and the safety for children under 18 years old has not been established. Caution is needed as overdose may affect kidney and liver functions, and if overdose is suspected, immediate consultation with healthcare professionals is required. This medication should not be mixed with calcium-containing solutions or other intravenous drugs and must only be administered by intravenous injection. After use, the syringe and needle should not be reused and should be disposed of safely.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering and at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness.
It is an injectable solution in a colorless and transparent prefilled syringe, with a single-use needle attached.
1 vial/3mL/prefilled syringe
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ibandronate Sodium Monohydrate 3.375mg
Injections · Prescription medication
Lite Pharmtech Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.